{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:10:31Z","timestamp":1787062231512,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The optimized synthesis of [5-oxo-4,4-diphenylimidazolidin-2-ylidene]cyanamide, which is known as 2-cyanoguanidinophenytoin (CNG-DPH) (3), and (imidazo[4,5-d]imidazole-2,5-diylidine)dicyanamide (4) has been reported in the present work. Furthermore, new Mannich bases derived from CNG-DPH were synthesized via its reaction with formaldehyde and using the corresponding amines, piperidine (base 5), and morpholine (base 6). Also, the antimicrobial activity and X-ray crystal structures for CNG-DPH and their Mannich bases were studied. The bases\n                    <jats:bold>3<\/jats:bold>\n                    and\n                    <jats:bold>6<\/jats:bold>\n                    crystallized in a monoclinic system; the crystal structure of\n                    <jats:bold>3<\/jats:bold>\n                    containing four molecules in the unit cell with a\n                    <jats:italic>P<\/jats:italic>\n                    2\n                    <jats:sub>1<\/jats:sub>\n                    \/\n                    <jats:italic>c<\/jats:italic>\n                    space group. The unit cell of\n                    <jats:bold>6<\/jats:bold>\n                    has eight molecules with a\n                    <jats:italic>C<\/jats:italic>\n                    2\/\n                    <jats:italic>c<\/jats:italic>\n                    space group. The inter and intra hydrogen bond contacts packed and stabilized both of the structures. The morpholine\u00a0ring of base\n                    <jats:bold>6<\/jats:bold>\n                    demonstrated a distinctive chair configuration. Mannich bases\n                    <jats:bold>5<\/jats:bold>\n                    and\n                    <jats:bold>6<\/jats:bold>\n                    showed promising antimicrobial effects. base\n                    <jats:bold>4<\/jats:bold>\n                    has a greater percentage for in vitro cytotoxicity (IC\n                    <jats:sub>50<\/jats:sub>\n                    ) against normal cells, whereas\n                    <jats:bold>3<\/jats:bold>\n                    has the lowest ratio.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-45533-1","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T11:03:08Z","timestamp":1699527788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Synthesis, X-ray crystallography and antimicrobial activity of 2-cyanoguanidinophenytoin"],"prefix":"10.1038","volume":"13","author":[{"given":"Ahmed F.","family":"Mabied","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr H.","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antar A.","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha M.","family":"Tiama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer A.","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"issue":"591","key":"45533_CR1","first-page":"594","volume":"20","author":"TR Rodgers","year":"1977","unstructured":"Rodgers, T. R., LaMontagne, M. P., Markovac, A. & Ash, A. B. Hydantoins as antitumor agents. J. Med. Chem. 20(591), 594 (1977).","journal-title":"J. Med. Chem."},{"key":"45533_CR2","first-page":"912","volume":"52","author":"J Knabe","year":"1997","unstructured":"Knabe, J., Baldauf, J. & Ahlhem, A. Racemates and enantiomers of basic, substituted 5-phenylhydantoins, synthesis and anti-arrhythmic action. Pharmazie 52, 912\u2013919 (1997).","journal-title":"Pharmazie"},{"issue":"355","key":"45533_CR3","first-page":"366","volume":"10","author":"S Sholl","year":"1999","unstructured":"Sholl, S., Koch, A., Henning, D., Kempter, G. & Kleinpeter, E. The influence of structure and lipophilicity of hydantoin derivatives on anticonvulsant activity. Struct. Chem. 10(355), 366 (1999).","journal-title":"Struct. Chem."},{"key":"45533_CR4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0040-4020(03)00033-4","volume":"59","author":"GG Muccioli","year":"2003","unstructured":"Muccioli, G. G. et al. A rapid and efficient microwave-assisted synthesis of hydantoins and thiohydantoins. Tetrahedron 59, 1301\u20131307 (2003).","journal-title":"Tetrahedron"},{"key":"45533_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1021\/jm040869i","volume":"48","author":"N Opa\u010di\u0107","year":"2005","unstructured":"Opa\u010di\u0107, N. et al. The novel l- and d-amino acid derivatives of hydroxyurea and hydantoins: Synthesis, X-ray crystal structure study, and cytostatic and antiviral activity evaluations. J. Med. Chem. 48, 475\u2013482 (2005).","journal-title":"J. Med. Chem."},{"issue":"1259","key":"45533_CR6","first-page":"1265","volume":"55","author":"E Lattmann","year":"2013","unstructured":"Lattmann, E. et al. Synthesis and evaluation of 5-arylated 2(5 H)-furanones and 2-arylated pyridazin-3(2 H)-ones as anti-cancer agents. J. Pharm. Pharmacol. 55(1259), 1265 (2013).","journal-title":"J. Pharm. Pharmacol."},{"issue":"2375","key":"45533_CR7","first-page":"2380","volume":"8","author":"A Boeijen","year":"1998","unstructured":"Boeijen, A., Kruijtzer, J. A. & Liskamp, R. M. Combinatorial chemistry of hydantoins. Bioorg. Med. Chem. Lett. 8(2375), 2380 (1998).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"45533_CR8","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1212\/01.WNL.0000123693.82339.FC","volume":"62","author":"JA French","year":"2004","unstructured":"French, J. A. et al. Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62, 1252 (2004).","journal-title":"Neurology"},{"key":"45533_CR9","volume-title":"Atlas: Epilepsy Care in the World","author":"World Health Organization","year":"2005","unstructured":"World Health Organization. Atlas: Epilepsy Care in the World (World Health Organization, 2005)."},{"key":"45533_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrn1430","volume":"5","author":"MA Rogawski","year":"2004","unstructured":"Rogawski, M. A. & L\u00f6scher, W. The neurobiology of antiepileptic drugs. Nat. Rev. Neurosci. 5, 553\u2013564 (2004).","journal-title":"Nat. Rev. Neurosci."},{"issue":"410","key":"45533_CR11","first-page":"414","volume":"6","author":"AS Troupin","year":"1979","unstructured":"Troupin, A. S., Friel, P., Lovely, M. P. & Wilensky, A. J. Clinical pharmacology of mephenytoin and ethotoin. Ann. Neurol. 6(410), 414 (1979).","journal-title":"Ann. Neurol."},{"key":"45533_CR12","doi-asserted-by":"publisher","first-page":"15419","DOI":"10.1016\/S0021-9258(17)40694-6","volume":"269","author":"SM de Morais","year":"1994","unstructured":"de Morais, S. M. et al. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J. Biol. Chem. 269, 15419\u201315422 (1994).","journal-title":"J. Biol. Chem."},{"issue":"871","key":"45533_CR13","first-page":"875","volume":"27","author":"M Moguilewsky","year":"1987","unstructured":"Moguilewsky, M., Bertagna, C. & Hucher, M. Pharmacological and clinical studies of the antiandrogen Anandron. J. Steroid Biochem. 27(871), 875 (1987).","journal-title":"J. Steroid Biochem."},{"issue":"1742","key":"45533_CR14","first-page":"1744","volume":"169","author":"W Kassouf","year":"2003","unstructured":"Kassouf, W., Tanguay, S. & Aprikian, A. G. Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails. J. Urol. 169(1742), 1744 (2003).","journal-title":"J. Urol."},{"issue":"6829","key":"45533_CR15","first-page":"6834","volume":"55","author":"W Liu","year":"2007","unstructured":"Liu, W. et al. Preparation of polyclonal antibodies to a derivative of 1-aminohydantoin (AHD) and development of an indirect competitive ELISA for the detection of nitrofurantoin residue in water. J. Agric. Food Chem. 55(6829), 6834 (2007).","journal-title":"J. Agric. Food Chem."},{"key":"45533_CR16","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1039\/C4AY00487F","volume":"6","author":"Q Wang","year":"2014","unstructured":"Wang, Q. et al. Development of a direct competitive chemiluminescent ELISA for the detection of nitrofurantoin metabolite 1-amino-hydantoin in fish and honey. Anal. Methods 6, 4414\u20134420 (2014).","journal-title":"Anal. Methods"},{"key":"45533_CR17","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.1016\/j.bmc.2012.08.062","volume":"20","author":"S Murasawa","year":"2012","unstructured":"Murasawa, S. et al. Small-molecular inhibitors of Ca2+-induced mitochondrial permeability transition (MPT) derived from muscle relaxant dantrolene. Bioorg. Med. Chem. 20, 6384\u20136393 (2012).","journal-title":"Bioorg. Med. Chem."},{"key":"45533_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.bmc.2011.10.077","volume":"20","author":"K Kumata","year":"2012","unstructured":"Kumata, K. et al. Radiosynthesis of [13N]dantrolene, a positron emission tomography probe for breast cancer resistant protein, using no-carrier-added [13N]ammonia. Bioorg. Med. Chem. 20, 305\u2013310 (2012).","journal-title":"Bioorg. Med. Chem."},{"key":"45533_CR19","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1016\/j.tetasy.2004.07.061","volume":"15","author":"SG Burton","year":"2004","unstructured":"Burton, S. G. & Dorrington, R. A. Hydantoin-hydrolysing enzymes for the enantioselective production of amino acids: New insights and applications. Tetrahedr. Asymmetry 15, 2737\u20132741 (2004).","journal-title":"Tetrahedr. Asymmetry"},{"key":"45533_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0958-1669(01)00263-4","volume":"12","author":"J Altenbuchner","year":"2001","unstructured":"Altenbuchner, J., Siemann-Herzberg, M. & Syldatk, C. Hydantoinases and related enzymes as biocatalysts for the synthesis of unnatural chiral amino acids. Curr. Opin. Biotechnol. 12, 559\u2013563 (2001).","journal-title":"Curr. Opin. Biotechnol."},{"key":"45533_CR21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/BF00910219","volume":"101","author":"L Call","year":"1970","unstructured":"Call, L. Derivate des 5,5-diphenyl-glykocyamidins. Monatsh. Chem. 101, 344\u2013346 (1970).","journal-title":"Monatsh. Chem."},{"key":"45533_CR22","first-page":"385","volume":"57","author":"HW Schramm","year":"1989","unstructured":"Schramm, H. W. Studies on the reaction of cyanguanidine with benzil. Investigations into the reactions of carbonic acid diamides with alpha-hydroxy ketones and alpha-diketones, 1st communication. Sci. Pharm. 57, 385\u2013390 (1989).","journal-title":"Sci. Pharm."},{"key":"45533_CR23","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s00706-017-2037-2","volume":"148","author":"AH Moustafa","year":"2017","unstructured":"Moustafa, A. H. & Amer, A. A. Utility of bis(methylthio)methylene malononitrile as a synthon in the synthesis of new poly-functionalized cyanoiminopyrimidines. Monatsh. Chem. 148, 2129\u20132134 (2017).","journal-title":"Monatsh. Chem."},{"key":"45533_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.tet.2017.11.074","volume":"74","author":"AH Moustafa","year":"2018","unstructured":"Moustafa, A. H. & Amer, A. A. Unexpected products from the reaction of chalcones with cyanoguanidine. Tetrahedron 74, 324\u2013328 (2018).","journal-title":"Tetrahedron"},{"key":"45533_CR25","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s11030-017-9762-7","volume":"21","author":"AA Amer","year":"2017","unstructured":"Amer, A. A. & Moustafa, A. H. New route for the synthesis of new cyanoimino- and cyanoaminopyrimidines. Mol. Divers. 21, 875\u2013880 (2017).","journal-title":"Mol. Divers."},{"key":"45533_CR26","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1002\/jhet.2972","volume":"54","author":"AH Moustafa","year":"2017","unstructured":"Moustafa, A. H., Ahmed, W. W. & Khodairy, A. Syntheses of some new N-linked pyrimidine-2-amines with pyrazinopyrimidines, thienopyrimidines, and benzazoles via reactions of various nucleophiles with cyanamides. J. Heterocycl. Chem. 54, 3490\u20133497 (2017).","journal-title":"J. Heterocycl. Chem."},{"key":"45533_CR27","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1080\/00397911.2019.1626892","volume":"49","author":"BRM Hussein","year":"2019","unstructured":"Hussein, B. R. M. & Moustafa, A. H. A regioselective and convenient one-pot multicomponent synthesis of polyfunctionalized 4-aryl-2-cyanoimino-3,4-dihydro-1H-pyrido[2,3-d]pyrimidines. Synth. Commun. 49, 2401\u20132410 (2019).","journal-title":"Synth. Commun."},{"key":"45533_CR28","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00706-021-02838-z","volume":"152","author":"AH Moustafa","year":"2021","unstructured":"Moustafa, A. H. & Hussein, B. R. M. Reaction of arylglyoxal hydrate derivatives with cyanoguanidine under benzilic rearrangement effect. Monatsh. Chem. 152, 1285\u20131290 (2021).","journal-title":"Monatsh. Chem."},{"issue":"8","key":"45533_CR29","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1080\/00397911.2022.2072747","volume":"52","author":"AH Moustafa","year":"2022","unstructured":"Moustafa, A. H. & Hussein, B. R. M. A methodological approach for the synthesis of 4-aryl-8-arylidene-2-cyanoimino-1,2,3,4,5,6,7,8-octahydroquinazolines. Synth. Commun. 52(8), 1131\u20131138 (2022).","journal-title":"Synth. Commun."},{"issue":"10","key":"45533_CR30","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1021\/js960093b","volume":"85","author":"DM Lambert","year":"1995","unstructured":"Lambert, D. M., Masereel, B., Gallez, B., Geurts, M. & Scriba, G. K. E. Bioavailability and anticonvulsant activity of 2-cyanoguanidinophenytoin, a structural analogue of phenytoin. J. Pharm. Sci. 85(10), 1077 (1995).","journal-title":"J. Pharm. Sci."},{"key":"45533_CR31","doi-asserted-by":"publisher","first-page":"103050","DOI":"10.1016\/j.arabjc.2021.103050","volume":"14","author":"S Farooq","year":"2021","unstructured":"Farooq, S., Haq, I.-U. & Ullah, N. Synthesis, characterization and biological evaluation of N-Mannich base derivatives of 2-phenyl-2-imidazoline as potential antioxidants, enzyme inhibitors, antimicrobials, cytotoxic and anti-inflammatory agents. Arab. J. Chem. 14, 103050 (2021).","journal-title":"Arab. J. Chem."},{"key":"45533_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/ph14050399","volume":"14","author":"LH Al-Wahaibi","year":"2021","unstructured":"Al-Wahaibi, L. H. et al. Design, synthesis, and antibacterial screening of some novel heteroaryl-based ciprofloxacin derivatives as DNA gyrase and topoisomerase iv inhibitors. Pharmaceuticals 14, 399 (2021).","journal-title":"Pharmaceuticals"},{"key":"45533_CR33","doi-asserted-by":"publisher","first-page":"130908","DOI":"10.1016\/j.molstruc.2021.130908","volume":"1244","author":"KB Ajit","year":"2021","unstructured":"Ajit, K. B., Monalisa, M., Sudhir, K. P. & Rabindra, N. P. Design, molecular docking, and antimicrobial assessment of newly synthesized phytochemical thymol Mannich base derivatives. J. Mol. Struct. 1244, 130908 (2021).","journal-title":"J. Mol. Struct."},{"key":"45533_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1021\/jm00325a025","volume":"8","author":"MB Winstead","year":"1965","unstructured":"Winstead, M. B. et al. Substitution in the hydantoin ring. I. N-3-aminomethyl derivatives. J. Med. Chem. 8, 117\u2013120 (1965).","journal-title":"J. Med. Chem."},{"issue":"5","key":"45533_CR35","first-page":"1198","volume":"3","author":"PP Mistry","year":"2012","unstructured":"Mistry, P. P. & Desai, V. A. Evaluating one-pot synthesis of 3,5-substituted hydantoins and their biological studies. Der Chem. Sin. 3(5), 1198\u20131203 (2012).","journal-title":"Der Chem. Sin."},{"key":"45533_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0378-5173(80)90057-5","volume":"7","author":"H Bundgaard","year":"1980","unstructured":"Bundgaard, H. & Johansen, M. Pro-drugs as drug delivery systems XV. Bioreversible derivatization of phenytoin, acetazolamide, chlorzoxazone and various other NH-acidic compounds by N-aminomethylation to effect enhanced dissolution rates. Int. J. Pharm. 7, 129\u2013136 (1980).","journal-title":"Int. J. Pharm."},{"key":"45533_CR37","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1021\/ci00021a024","volume":"34","author":"P Dang","year":"1994","unstructured":"Dang, P. & Madan, A. K. Structure-activity study on anticonvulsant (Thio) hydantoins using molecular connectivity indices. J. Chem. Inf. Comput. Sci. 34, 1162\u20131166 (1994).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"45533_CR38","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1055\/s-1986-31874","volume":"12","author":"R Carrau","year":"1986","unstructured":"Carrau, R., Freire, R., Hern\u00e1ndez, R. & Su\u00e1rez, E. Dehydrogenation of cyanamides. An approach to cyanimides and carbonyl compounds. Synthesis (Stuttg.) 12, 1055 (1986).","journal-title":"Synthesis (Stuttg.)"},{"issue":"1","key":"45533_CR39","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/jhet.2621","volume":"54","author":"AS Shestakov","year":"2017","unstructured":"Shestakov, A. S. et al. Detailed studies of the alkylation sides of pyridin-2-yl and 4,6-dimethylpyrimidin-2-yl-cyanamides. J. Heterocycl. Chem. 54(1), 551\u2013560 (2017).","journal-title":"J. Heterocycl. Chem."},{"key":"45533_CR40","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1107\/S0108270195001661","volume":"C51","author":"L Dupont","year":"1995","unstructured":"Dupont, L., Masereel, B., Lambert, D. & Scriba, G. 2-Cyanoimino-5,5-diphenyl-4-imidazolinone monohydrate. Acta Cryst. C51, 1901\u20131903. https:\/\/doi.org\/10.1107\/S0108270195001661 (1995).","journal-title":"Acta Cryst."},{"key":"45533_CR41","doi-asserted-by":"publisher","DOI":"10.1039\/DT98900000S1","author":"AG Orpen","year":"1989","unstructured":"Orpen, A. G. et al. Supplement. Tables of bond lengths determined by X-ray and neutron diffraction. Part 2. Organometallic compounds and co-ordination complexes of the d- and f-block metals. J. Chem. Soc. Dalton Trans. https:\/\/doi.org\/10.1039\/DT98900000S1 (1989).","journal-title":"J. Chem. Soc. Dalton Trans."},{"key":"45533_CR42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/BF01200485","volume":"8","author":"JCA Boeyens","year":"1978","unstructured":"Boeyens, J. C. A. The conformation of six-membered rings. J. Cryst. Mol. Struct. 8, 317\u2013320. https:\/\/doi.org\/10.1007\/BF01200485 (1978).","journal-title":"J. Cryst. Mol. Struct."},{"key":"45533_CR43","volume-title":"COLLECT","author":"RWW Hooft","year":"1998","unstructured":"Hooft, R. W. W. COLLECT (Nonius BV, 1998)."},{"key":"45533_CR44","first-page":"435","volume":"27","author":"A Altomare","year":"1994","unstructured":"Altomare, A. et al. SIR 92\u2014a program for automatic solution of crystal structures by direct methods. J. Appl. Cryst. 27, 435 (1994).","journal-title":"J. Appl. Cryst."},{"key":"45533_CR45","volume-title":"SHELXS-97. Program for Crystal Structure Solution and Refinement","author":"GM Sheldrick","year":"1997","unstructured":"Sheldrick, G. M. SHELXS-97. Program for Crystal Structure Solution and Refinement (University of Gottingen, 1997)."},{"key":"45533_CR46","volume-title":"maXus Computer Program for the Solution and Refinement of Crystal Structures","author":"S Mackay","year":"1999","unstructured":"Mackay, S., Gilmore, C. J., Edwards, C., Stewart, N. & Shankland, K. maXus Computer Program for the Solution and Refinement of Crystal Structures (Japan & The University of Glasgow, 1999)."},{"key":"45533_CR47","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1107\/S0021889810025598","volume":"43","author":"RI Cooper","year":"2010","unstructured":"Cooper, R. I., Thompson, A. L. & Watkin, D. J. CRYSTALS enhancements: Dealing with hydrogen atoms in refinement. J. Appl. Cryst. 43, 1100\u20131107 (2010).","journal-title":"J. Appl. Cryst."},{"key":"45533_CR48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1107\/S090744490804362X","volume":"65","author":"AL Spek","year":"2009","unstructured":"Spek, A. L. Structure validation in chemical crystallography. Acta Crystallogr. D Biol Crystallogr. 65, 148\u2013155 (2009).","journal-title":"Acta Crystallogr. D Biol Crystallogr."},{"issue":"1","key":"45533_CR49","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1107\/S1600576719014092","volume":"53","author":"CF Macrae","year":"2020","unstructured":"Macrae, C. F. et al. Mercury 4.0: From visualization to analysis, design and prediction. J. Appl. Crystallogr. 53(1), 226\u2013235 (2020).","journal-title":"J. Appl. Crystallogr."},{"key":"45533_CR50","unstructured":"Cambridge Crystallographic Data Centre. https:\/\/www.ccdc.cam.ac.uk\/structures\/."},{"key":"45533_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20546\/ijcmas.2017.604.001","volume":"6","author":"GM El-Sherbiny","year":"2017","unstructured":"El-Sherbiny, G. M., Moghannem, S. A. & Sharaf, M. H. Antimicrobial activities and cytotoxicity of Sisymbrium irio L. extract against multi-drug resistant bacteria (MDRB) and Candida albicans. Int. J. Curr. Microbiol. Appl. Sci. 6, 1\u201313 (2017).","journal-title":"Int. J. Curr. Microbiol. Appl. Sci."},{"key":"45533_CR52","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Seventh Informational Supplement. CLSI Document M100\u2013S27","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2017","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Seventh Informational Supplement. CLSI Document M100\u2013S27 (Clinical and Laboratory Standards Institute, 2017)."},{"key":"45533_CR53","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2147\/DDDT.S344750","volume":"16","author":"AE Abdallah","year":"2022","unstructured":"Abdallah, A. E. et al. New series of VEGFR-2 inhibitors and apoptosis enhancers: Design, synthesis and biological evaluation. Drug Des. Dev. Therapy 16, 587 (2022).","journal-title":"Drug Des. Dev. Therapy"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45533-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45533-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45533-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T11:22:05Z","timestamp":1699528925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45533-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["45533"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-45533-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,9]]},"assertion":[{"value":"8 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19510"}}